Nicholas Belviso

2PUBLICATIONS
11CO-AUTHORS
Medical infection agents (incl. prions)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 18, 2026
Time-dependent divergence in infection risks among patients with multiple sclerosis treated with fumarates versus anti-CD20 monoclonal antibodies.

|Jun 21, 2026
Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naïve people with multiple sclerosis.

Pageof 1

Frequent Collaborators

2 joint publications

Boyang Bian

1 joint publications

Heidi Crayton

1 joint publications

Christopher Eckstein

1 joint publications

Kyle Smoot